Neurocrine Biosciences to Participate at Investor Conferences in December

The 7th Annual Evercore HealthCONx Conference on December 3Citi's 2024 Global Healthcare Conference on December 4SAN DIEGO, Nov. 26, 2024 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will participate at two upcoming investor conferences in December. Chief Executive Officer Kyle Gano, Chief Financial Officer Matt Abernethy, and Vice-President of Investor Relations Todd Tushla will present at: The 7th Annual Evercore HealthCONx Conference at 10:50 a.m. Eastern Time on Tuesday December 3, 2024 i ...